코르티코스테로이드 시장 규모, 점유율, 성장 분석 : 제품 유형별, 투여 경로별, 적응증별, 판매 채널별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Corticosteroids Market size was valued at USD 6.2 Billion in 2024 and is poised to grow from USD 6.53 Billion in 2025 to USD 9.84 Billion by 2033, growing at a CAGR of 5.27% during the forecast period (2026-2033).

The global corticosteroids market is pivotal in addressing inflammation, autoimmune disorders, and endocrine conditions, driven by the crucial role these drugs play in symptom relief across various healthcare settings. Transitioning from a focus on generic prednisone, the market now features a diverse product range, including dexamethasone, methylprednisolone, and inhaled formulations. The surge in chronic respiratory diseases and oncology treatments has significantly influenced demand, prompting innovations and increased sales. The rise of biosimilar injectables has further enhanced market accessibility, especially in cost-sensitive regions. Additionally, the integration of artificial intelligence is revolutionizing personalized therapy, optimizing dosage and treatment methods based on individual patient data, ultimately leading to more effective and tailored corticosteroid treatments while fostering innovation and investment throughout the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Corticosteroids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Corticosteroids Market Segments Analysis

Global corticosteroids market is segmented by product type, route of administration, application indication, sales channel, distribution channel and region. Based on product type, the market is segmented into Glucocorticoids and Mineralocorticoids. Based on route of administration, the market is segmented into Topical Formulations, Injectable Formulations, Oral Formulations and Inhaled Formulations. Based on application indication, the market is segmented into Skin Allergies, Rheumatology Indications, Acute Respiratory Diseases, Gastroenterology, Endocrinology and Others. Based on sales channel, the market is segmented into Online and Offline. Based on distribution channel, the market is segmented into Direct and Indirect. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Corticosteroids Market

The increasing prevalence of chronic inflammatory and autoimmune diseases, including asthma and rheumatoid arthritis, drives a consistent demand for corticosteroid treatments. This ongoing demand compels manufacturers to enhance production capabilities and develop new formulations that enhance patient adherence. As healthcare providers recognize this persistent therapeutic need, they are more inclined to prescribe corticosteroids across a variety of medical disciplines, further boosting market activity and supporting revenue growth for both well-established companies and newcomers. The diverse therapeutic applications and proven safety records of corticosteroids give prescribers confidence, while ongoing clinical research continues to uncover new uses, thereby extending the product lifecycle and fostering market stability.

Restraints in the Global Corticosteroids Market

The global corticosteroids market faces significant restrictions due to the stringent regulations imposed by regulatory agencies, which mandate thorough evaluation of safety, efficacy, and quality for corticosteroid products. This necessitates extensive pre-clinical and clinical data prior to market entry, resulting in prolonged timelines and increased development costs. Such challenges can deter smaller companies from venturing into the market, curtailing the introduction of innovative formulations. Furthermore, the heavy resource allocation needed for compliance activities can delay product launches and diminish market dynamism, ultimately impacting growth potential. Ongoing post-marketing surveillance requirements also add to the operational burdens for manufacturers over the long term.

Market Trends of the Global Corticosteroids Market

The Global Corticosteroids market is witnessing a significant trend towards precision formulation expansion, as the focus on personalized medicine intensifies. Pharmaceutical companies are increasingly developing corticosteroid formulations that precisely target specific inflammatory pathways, thereby reducing systemic exposure and enhancing treatment efficacy. Advanced delivery technologies, including nanocarriers, inhalable dry powders, and transdermal patches, are enabling clinicians to customize dosing regimens according to individual patient profiles. This evolution is fostering collaboration between biotech innovators and traditional manufacturers, resulting in a diverse pipeline of differentiated products that aim to meet the unmet needs in areas such as asthma, dermatology, and ocular disorders globally, promoting sustainable healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Corticosteroids Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Glucocorticoids
• Mineralocorticoids

Global Corticosteroids Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Topical Formulations
• Injectable Formulations
• Oral Formulations
• Inhaled Formulations

Global Corticosteroids Market Size by Application Indication & CAGR (2026-2033)

• Market Overview
• Skin Allergies
• Rheumatology Indications
• Acute Respiratory Diseases
• Gastroenterology
• Endocrinology
• Others

Global Corticosteroids Market Size by Sales Channel & CAGR (2026-2033)

• Market Overview
• Online
• Offline

Global Corticosteroids Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct
• Indirect

Global Corticosteroids Market Size & CAGR (2026-2033)

• North America (Product Type, Route of Administration, Application Indication, Sales Channel, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Route of Administration, Application Indication, Sales Channel, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Route of Administration, Application Indication, Sales Channel, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Route of Administration, Application Indication, Sales Channel, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Route of Administration, Application Indication, Sales Channel, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amneal Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations